← FDA Drug Approvals (Drugs@FDA)
AFINITOR DISPERZ
NDA · New Drug Application · Sponsor: NOVARTIS PHARM · Approved 2012-08-29
Drug application
- FDA Application #
NDA203985- Application type
- New Drug Application
- Brand name
- AFINITOR DISPERZ
- Generic name
- EVEROLIMUS
- Active ingredients
- EVEROLIMUS
- Dosage form
- TABLET, FOR SUSPENSION
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- NOVARTIS PHARM
- Manufacturer
- Novartis Pharmaceuticals Corporation
- First approval
- 2012-08-29
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown